668 related articles for article (PubMed ID: 34491806)
1. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
3. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
[TBL] [Abstract][Full Text] [Related]
4. The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study.
Crook P; Logan C; Mazzella A; Wake RM; Cusinato M; Yau T; Ong YE; Planche T; Basarab M; Bicanic T
BMC Infect Dis; 2023 Nov; 23(1):808. PubMed ID: 37978457
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
6. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
Bolker A; Coe K; Smith J; Stevenson K; Wang SH; Reed E
Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115558. PubMed ID: 34731685
[TBL] [Abstract][Full Text] [Related]
7. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
8. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
10. Bacterial infections and patterns of antibiotic use in patients with COVID-19.
Goncalves Mendes Neto A; Lo KB; Wattoo A; Salacup G; Pelayo J; DeJoy R; Bhargav R; Gul F; Peterson E; Albano J; Patarroyo-Aponte G; Rangaswami J; Azmaiparashvili Z
J Med Virol; 2021 Mar; 93(3):1489-1495. PubMed ID: 32808695
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline.
Sieswerda E; de Boer MGJ; Bonten MMJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; van de Garde EMW; Verheij TJ; van der Eerden MM; Prins JM; Wiersinga WJ
Clin Microbiol Infect; 2021 Jan; 27(1):61-66. PubMed ID: 33010444
[TBL] [Abstract][Full Text] [Related]
12. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and outcomes associated with community-onset and hospital-acquired coinfection in patients hospitalized for coronavirus disease 2019 (COVID-19): A multihospital cohort study.
Petty LA; Flanders SA; Vaughn VM; Ratz D; O'Malley M; Malani AN; Washer L; Kim T; Kocher KE; Kaatz S; Czilok T; McLaughlin E; Prescott HC; Chopra V; Gandhi T
Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1184-1193. PubMed ID: 34308805
[TBL] [Abstract][Full Text] [Related]
15. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022.
Shah MM; Patel K; Milucky J; Taylor CA; Reingold A; Armistead I; Meek J; Anderson EJ; Weigel A; Reeg L; Como-Sabetti K; Ropp SL; Muse A; Bushey S; Shiltz E; Sutton M; Talbot HK; Chatelain R; Havers FP;
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13107. PubMed ID: 36875205
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
[TBL] [Abstract][Full Text] [Related]
17. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
[TBL] [Abstract][Full Text] [Related]
18. Observational Study on Secondary Bacterial Infection and the Use of Antibiotics in COVID-19 Patients Treated in a Tertiary Referral Hospital.
Lie KC; Shakinah S; Pasaribu A; Sinto R; Nainggolan L
Acta Med Indones; 2022 Apr; 54(2):161-169. PubMed ID: 35818653
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: a retrospective cohort study.
Wang M; Li W; Wang H; Song P
Antimicrob Resist Infect Control; 2024 Apr; 13(1):42. PubMed ID: 38616284
[TBL] [Abstract][Full Text] [Related]
20. [Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy].
Vidal-Cortés P; Nieto Del Olmo J; Tizón Varela AI; Seoane Fernández E; Eiras Abalde F; Blanco Chapela J; Larrañaga Sigwald L; Suárez Fernández DE; Fernández Ugidos P; Del Río Carbajo L
Rev Esp Quimioter; 2023 Dec; 36(6):612-620. PubMed ID: 37743661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
